Aim of the study is to compare the effect of myoinositol and metformin in the resumption of
the spontaneous menstrual cycle in patients diagnosed with PCOS or having oligo/amenorrhea,
reduction in weight and BMI, Improvement in the biochemical and clinical profile of patients
with the polycystic syndrome.
The secondary outcome measured will be the rate of pregnancy, miscarriage and term pregnancy
among these patients inducted in the study.
It will be a Three-arm prospective double-blind study. this clinical trial will be registered
in Public registry. this RCT will be based on CONSORT statement. The patient coming to
Gynecology OPD will be randomized into 3 groups GROUP A ( metformin 500 mg TDS), GROUP B(
myoinositol 2mg x BD ), GROUP C.(both metformin,& myoinositol).each group will take folic
acid and will be asked for lifestyle modifications.